<- Go Home
GlycoMimetics, Inc.
GlycoMimetics, Inc., a biotechnology company, engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, Maryland.
Market Cap
$18.7M
Volume
6.5M
Cash and Equivalents
$10.7M
EBITDA
-$32.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$3.36
52 Week Low
$0.14
Dividend
N/A
Price / Book Value
3.52
Price / Earnings
-0.49
Price / Tangible Book Value
3.52
Enterprise Value
$8.1M
Enterprise Value / EBITDA
-0.26
Operating Income
-$32.5M
Return on Equity
173.25%
Return on Assets
-72.04
Cash and Short Term Investments
$10.7M
Debt
$66.8K
Equity
$5.3M
Revenue
N/A
Unlevered FCF
-$14.3M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium